Related Experiment Video
Updated: Mar 24, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glycated Hemoglobin A1c Levels Are Not Affected by Critical Illness
Nora Luethi1, Luca Cioccari, Aiko Tanaka
11Department of Intensive Care, Austin Hospital, The University of Melbourne, Melbourne, VIC, Australia.2Department of Anesthesiology and Intensive Care, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.3Discipline of Acute Care Medicine, Department of Intensive Care, University of Adelaide, Adelaide, SA, Australia.4Section of Anaesthesia and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.5Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Insights
Glycated hemoglobin A1c (HbA1c) measured in the ICU reliably reflects patients' long-term glycemic control. Critical illness does not significantly alter HbA1c levels, validating its use for guiding diabetes treatment.
Area of Science:
- Endocrinology
- Critical Care Medicine
- Clinical Chemistry
Background:
- Glycated hemoglobin A1c (HbA1c) is a key indicator of long-term glycemic control in diabetic patients.
- Concerns exist that critical illness may affect HbA1c levels, potentially misrepresenting a patient's usual glycemic status upon ICU admission.
Purpose of the Study:
- To evaluate the relationship between HbA1c levels measured at ICU admission and premorbid HbA1c levels.
- To determine if critical illness alters HbA1c measurements.
Main Methods:
- Retrospective observational cohort study involving 69 diabetic patients admitted to two tertiary ICUs in Australia.
- HbA1c levels were measured upon ICU admission and from records within the preceding 30 days.
Main Results:
- Mean (SD) HbA1c was 7.5% (1.8%) on ICU admission and 7.8% (2.0%) pre-admission.
- A strong correlation (r = 0.89, p < 0.001) was observed between admission and premorbid HbA1c levels.
- No significant correlation was found between the change in HbA1c and the time elapsed between measurements.
Conclusions:
- Glycated hemoglobin A1c levels are not significantly altered by the acute onset of critical illness.
- HbA1c measured at ICU admission serves as a reliable estimate of chronic glycemic control.
- Admission HbA1c values can be effectively utilized to guide acute glycemic management in critically ill diabetic patients.
Objectives:
Glycated hemoglobin A1c is used to estimate glycemic control. However, its value upon ICU admission may be altered by critical illness and not reflect true glycemic status. We assessed the relationship between ICU admission glycated hemoglobin A1c and premorbid glycated hemoglobin A1c levels.
Design:
Retrospective observational cohort study.
Setting:
Two tertiary ICUs in Australia.
Patients:
Cohort of 69 critically ill patients with diabetes and glycated hemoglobin A1c levels measured upon ICU admission and during the month prior to admission.
Interventions:
Measurement of glycated hemoglobin A1c.
Measurements And Main Results:
Mean (SD) glycated hemoglobin A1c level was 7.5% (1.8%) upon ICU admission and 7.8% (2.0%) in previous measurements from the preceding 30 days. The change in glycated hemoglobin A1c did not correlate with time elapsed between the two measurements (r = 0.00005; p = 0.95), but there was a strong correlation between admission glycated hemoglobin A1c levels and premorbid glycated hemoglobin A1c levels (r = 0.89; p < 0.001).
Conclusions:
Glycated hemoglobin A1c levels are not altered by the onset of critical illness. Glycated hemoglobin A1c quantified at ICU admission can, therefore, be used to reliably estimate chronic glycemic control and guide acute glycemic therapy.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Acute Pancreatitis II: Clinical Manifestations and Management